You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways

 

Online download statistics by month:

Online download statistics by month: March 2021 to February 2026

AbstractFullPdf
Mar 202113413452
Apr 202113913951
May 2021818125
Jun 2021868626
Jul 2021737311
Aug 2021838314
Sep 2021525217
Oct 2021777738
Nov 2021707031
Dec 2021565618
Jan 2022424420
Feb 2022252516
Mar 2022383822
Apr 2022414221
May 2022383824
Jun 2022383819
Jul 2022333414
Aug 2022323319
Sep 2022383862
Oct 2022333321
Nov 2022404240
Dec 202218189
Jan 2023222211
Feb 2023414115
Mar 2023171914
Apr 2023212115
May 2023131310
Jun 2023212110
Jul 2023262622
Aug 2023131312
Sep 202327278
Oct 2023191919
Nov 2023292915
Dec 2023333317
Jan 2024353610
Feb 2024161612
Mar 2024171744
Apr 2024161620
May 2024414213
Jun 2024313012
Jul 2024434418
Aug 2024312812
Sep 2024383823
Oct 2024232318
Nov 2024181913
Dec 2024161711
Jan 2025434327
Feb 2025242418
Mar 2025323226
Apr 2025373719
May 2025222215
Jun 2025181918
Jul 2025110
Feb 2026110
Total205220631067